It is our mission to improve a patient’s quality of life by enabling them to benefit from personal insights at the genomic level of their disease.

Rotterdam, The Netherlands
Joined December 2009
SkylineDx retweeted
🗞️ Press news: Biocartis Initiates Commercialization in Europe of @SkylineDx 's Innovative #Merlin™ Assay (CE-IVD) for #Melanoma Patients. More info on investors.biocartis.com/en/p… bit.ly/3e9t4F1
4
6
🙌Soon available! The Merlin™ Test, developed by our partner @skylinedx BV, which helps identify #melanoma patients who may safely forgo the sentinel lymph node biopsy (SLNB)! ♥️ lnkd.in/ei-PfQud @Melanoma_doctor @MelanomaNetwork @melanoma_fund @theNCI @UmbertoMalapel1
1
6
🗞️ Press news: Biocartis Announces Presentation of First Prospective Validation Study Data of Merlin Test by Partner @SkylineDx at EADO2022 Conference 🇪🇸 More info on investors.biocartis.com/en/p…
1
5
Today is #WorldCancerDay! Explore how people living with cancer can be empowered thanks to #MedicalTechnologies 📽️Watch our series #ConnectingTheDots: bit.ly/3vpTO7t
1
2
Thanks to #DigitalHealth, simple diagnostic tests can enable delivery of more targeted treatments & empower #myeloma patients to take an active role in their recovery #ConnectingTheDots #NCDs 📽️Learn more: bit.ly/2ZUrcce
1
5
#Acquisitions & Partnerships : ~@pfizer acquires #AmplyxPharmaceuticals ~@Tridiuum & #NOCD partner on #OCD diagnosis ~@ButterflyNetInc $BFLY partners w/ @SientraInc $SIEN breast implant #ultrasound ~@skylinedx & @Biocartis_  partner to develop #melanoma risk test
1
2
New validation data on the Merlin test for #melanoma risk assessment by @WVUMedicine, @MayoClinic, @MayoClinicCIM and @SkylineDx: lnkd.in/gXmqZgg
4
5
SkylineDx retweeted
Biocartis, SkylineDx Partner to Develop Melanoma Nodal Metastasis Risk Test @Biocartis_ @skylinedx bit.ly/32EA4kc
1
3
Strong @Biocartis_ results this morning, 70% cartridge vol growth vs non-COVID19 impacted 1Q20. Impressive considering 68% growth in 1Q20. Novel partnership in melanoma with @skylinedx to top it off. $BCART
1
5
9
SkylineDx retweeted
📰 Press news: Biocartis and @SkylineDx Sign Collaboration to Develop the #Merlin Assay, a Test Predicting Risk for Nodal Metastasis in #Melanoma, on #Idylla™ 🤩 #NewAssay #HighValue #Rapid #Easy #Diagnostics #Melanoma 👉 investors.biocartis.com/en/p…
1
4
Biocartis & SkylineDx Sign Collaboration to Develop Test Predicting Risk for Nodal Metastasis in Melanoma, on Idylla globenewswire.com/news-relea… @Biocartis_ @skylinedx More Benelux life science business news at [LSBNL] at life-sciences-benelux.com/ne…
3
4
👉🛎️ Press news: Biocartis and @skylinedx 🇳🇱 🇺🇸 Sign Collaboration to Develop the #Merlin Assay, a Test Predicting Risk for Nodal Metastasis in #Melanoma, on #Idylla™ 😍 investors.biocartis.com/en/p…
📰 Press news: Biocartis and @SkylineDx Sign Collaboration to Develop the #Merlin Assay, a Test Predicting Risk for Nodal Metastasis in #Melanoma, on #Idylla™ 🤩 #NewAssay #HighValue #Rapid #Easy #Diagnostics #Melanoma 👉 investors.biocartis.com/en/p…
World Congress of Melanoma 2021: Check out the satellite symposium "Refining the role of SLNB?" concerning SNB and melanoma. Excellent work by Tina Hieken @TJH0828 Sponsored by @skylinedx vimeo.com/537616393/1882533b…
4
5
This is another utility of the CP-GEP test. In a very fruitful collaboration between @ErasmusMC and @SahlgrenskaAcad we show that the Merlin assay @skylinedx adds extra prognostic information in patients with stage II #melanoma
Validation of @axm27 @MayoClinic C-GEP model by @OlofssonBagge @skylinedx on 10th World Congress of Melanoma & 17th EADO Congress 2021 xitter.cf/skylinedx/status/13819… via @walls_io #melanoma #EADO2021
1/3 - Poster presentation at #10thWCM #eado2021 #10thworldcongressofmelanoma See poster below for more details 👇 high-res poster via this link: falconprogram.com/files/post… #diagnosticsispower
Happy to share our Swedish validation study using the Merlin Assay (CP-GEP) to guide the use of #sentinel node biopsy in patients with #melanoma at #eado2021
6
13
For those with an interest in high-risk #myeloma - our 'story behind the paper' on #MyelomaXI combined molecular risk profiling. Another great #UKMRA collaboration @profghjackson @CTRUmyeloma @profBigG go.nature.com/2XNlyDV
1
16
1
34
Skin cancer test by @axm27 at @MayoClinic and @skylinedx! Another great step towards implementing research results in clinical practice! skylinedx.com/news/skin-canc… ascopubs.org/doi/full/10.120…
2
4